C12N 2720/12011
Reoviridae
C12N2720/12011 (Reoviridae) appears on 389 US grants and 448 published applications in this corpus.
Search patents in C12N- Granted patents
- 389
- Published applications
- 448
- Assignees
- 271
- Inventors
- 891
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 17 | 0 |
| 1998 | 17 | 0 |
| 1999 | 16 | 0 |
| 2000 | 16 | 0 |
| 2001 | 9 | 2 |
| 2002 | 5 | 18 |
| 2003 | 10 | 20 |
| 2004 | 9 | 22 |
| 2005 | 4 | 22 |
| 2006 | 8 | 13 |
| 2007 | 13 | 9 |
| 2008 | 9 | 26 |
| 2009 | 8 | 16 |
| 2010 | 13 | 22 |
| 2011 | 9 | 22 |
| 2012 | 11 | 17 |
| 2013 | 9 | 22 |
| 2014 | 12 | 13 |
| 2015 | 5 | 12 |
| 2016 | 14 | 14 |
| 2017 | 11 | 22 |
| 2018 | 20 | 23 |
| 2019 | 18 | 22 |
| 2020 | 22 | 18 |
| 2021 | 14 | 17 |
| 2022 | 12 | 20 |
| 2023 | 10 | 15 |
| 2024 | 9 | 18 |
| 2025 | 9 | 12 |
| 2026 | 8 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2720/12311RotavirusIndexing code220
- C12N 2720/12211OrthoreovirusIndexing code79
- C12N 2720/12111OrbivirusIndexing code32
- C12N 2720/12034Use of virus or viral component as vaccineIndexing code27
- C12N 2720/12022New viral proteins or individual genes, new structural or functional aspects ofIndexing code26
- C12N 2720/12051Methods of production or purification of viral materialIndexing code26
- C12N 2720/12032Use of virus as therapeutic agent, other than vaccineIndexing code25
- C12N 2720/12021Viruses as suchIndexing code5
All 15 subgroupsShow fewer
- C12N 2720/12041Use of virus, viral particle or viral elements as a vectorIndexing code4
- C12N 2720/12061Methods of inactivation or attenuationIndexing code4
- C12N 2720/12033Use of viral protein as therapeutic agent other than vaccineIndexing code3
- C12N 2720/12023Virus like particles [vlp]Indexing code2
- C12N 2720/12031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2720/12071Demonstrated in vivo effectIndexing code0
- C12N 2720/12088For redistributionIndexing code0
Recent patents
- PCR method for the detection of equine rotavirus group B (ERVB) in biological samples7 Jul 2026US 12,674,212 B2University of Kentucky Research Foundation
- Viral extraction from cell culture16 Jun 2026US 12,655,397 B2National Research Council of Canada
- Attenuated avian reovirus strains 94826 C140 and 96139 C14014 Apr 2026US 12,599,659 B2University of Georgia Research Foundation, Inc.
- Protein crystal production method and crystalline structure analysis method14 Apr 2026US 12,600,999 B2Institute of Science Tokyo
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Expression constructs, fusogenic lipid-based nanoparticles and methods of use thereof8 Oct 2026US 2026/0308635 A1Oisin Biotechnologies, Inc.
- Muns fusion protein capable of forming microspheres and uses thereof27 Aug 2026US 2026/0248905 A1Universidade De Santiago De Compostela
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
- Trigger-inducible mrna circularization23 Jul 2026US 2026/0209789 A1Westlake University
- Mrna recombinant capping enzymes16 Jul 2026US 2026/0201350 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Oral vaccines118US 4,920,209 AAmerican Home Products Corporation · 1990
- Preparation of inactivated viral vaccines92US 4,693,981 AAdvanced Genetics Research Institute · 1987
- Recombinant flagellin vaccines92US 6,130,082 AAmerican Cyanamid Company · 2000
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence86US 5,223,424 APrutech Research And Development · 1993